ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

NCI May Support More Training Of Cancer Surgeons

May 23, 1975

NIH Defines Misconduct

December 9, 1994

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Five NCAB members complete terms.

February 20, 2004